E. Wist

3.0k citations

55 papers · 2.4k indexed · h-index 27

Impact in

Oncology top 2%
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Colorectal Cancer Surgical Treatments
- HER2/EGFR in Cancer Research
Complementary and alternative medicine top 1%
- Complementary and Alternative Medicine Studies

Papers in ⓘ

Oncology 25
- Cancer Treatment and Pharmacology 8
- Cancer survivorship and care 4
Complementary and alternative medicine 7
- Complementary and Alternative Medicine Studies 7

Co-authors: S. Kaasa (7 shared papers)Roy M. Bremnes (8 shared papers)Terje Risberg (11 shared papers)Suzanne Hagen (4 shared papers)Tom Wilsgaard (7 shared papers)Neil K. Aaronson (1 shared paper)Kristin Bjordal (1 shared paper)Anne Kvikstad (1 shared paper)
Journals: European Journal of Cancer (18 papers)British Journal of Cancer (3 papers)Journal of Clinical Oncology (3 papers)Acta Oncologica (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
Partner nations: Norway United States Sweden

In The Last Decade

E. Wist

54 papers receiving 2.3k citations

Peers

Countries citing papers authored by E. Wist

Since Specialization

Citations

This map shows the geographic impact of E. Wist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Wist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Wist more than expected).

Fields of papers citing papers by E. Wist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Wist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Wist. The network helps show where E. Wist may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Wist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Wist Line = papers co-authored together E. Wist links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy European Journal of Cancer ·S. Kaasa, Kristin Bjordal, Neil K. Aaronson, Torbjørn Moum, E. Wist, Suzanne Hagen, Anne Kvikstad	1995	318
2	Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group European Journal of Cancer ·J Sjöström, Carl Blomqvist, Henning T. Mouridsen, A Płużańska, S Ottosson-Lönn, Nils‐Olof Bengtsson, Bjørn Østenstad, Ingvil Mjaaland, M Palm-Sjövall, E. Wist, Vahur Valvere, H. Anderson, Jonas Bergh	1999	215
3	Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer British journal of surgery ·Kjell M. Tveit, I. Guldvog, Suzanne Hagen, Erik Trondsen, T. Harbitz, K. Nygaard, J. B. Nilsen, E. Wist, (unknown)	1997	168
4	Components of the metabolic syndrome in long-term survivors of testicular cancer Annals of Oncology ·Hege Sagstuen Haugnes, Nina Aass, Sophie D. Fosså, Olav Dahl, O. Klepp, E. Wist, Johan Svartberg, Tom Wilsgaard, Roy M. Bremnes	2006	132
5	Blood Pressure and Body Mass Index in Long-Term Survivors of Testicular Cancer Journal of Clinical Oncology ·H. Sagstuen, Nina Aass, S.D. Fosså, O. Dahl, Olbjørn Klepp, E. Wist, Tom Wilsgaard, Roy M. Bremnes	2005	123
6	Cancer patients use of nonproven therapy: a 5-year follow-up study. Journal of Clinical Oncology ·Terje Risberg, Eiliv Lund, E. Wist, S. Kaasa, Tom Wilsgaard	1998	116
7	Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors JNCI Journal of the National Cancer Institute ·Marianne Brydøy, Jan Oldenburg, O. Klepp, R. M. Bremnes, E. Wist, Tore Wentzel‐Larsen, Erik R. Hauge, Olav Dahl, S. D. Fosså	2009	111
8	Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy European Journal of Cancer ·Roy M. Bremnes, Kasper Jarlhelt Andersen, E. Wist	1995	90
9	Knowledge of and attitudes toward complementary and alternative therapies European Journal of Cancer ·Terje Risberg, Arne Kolstad, Yngve Bremnes, Harald Holte, E. Wist, Olav Mella, Olbjørn Klepp, Tom Wilsgaard, Barrie R. Cassileth	2004	71
10	The use of non-proven therapy among patients treated in norwegian oncological departments. A cross-sectional national multicentre study European Journal of Cancer ·Terje Risberg, Eiliv Lund, E. Wist, Olav Dahl, Stein Sundstrøm, O. K. Andersen, S. Kaasa	1995	61
11	Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer European Journal of Cancer ·Olbjørn Klepp, O. Dahl, Per Flodgren, Ulrika Stierner, Arne M. Olsson, J. Oldbring, Sten Nilsson, L Daehlin, Magnus Törnblom, R Småland, Hans Starkhammar, Leif Abramsson, E. Wist, Nils Raabe, Thomas Edekling, Eva Cavallin‐Ståhl	1997	60
12	The modification of melphalan toxicity in tumor bearing mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR2721) American Journal of Clinical Oncology ·Jeremy Millar, T J McElwain, R D Clutterbuck, E. Wist	1982	58
13	Does use of alternative medicine predict survival from cancer? European Journal of Cancer ·Terje Risberg, Andrew J. Vickers, Roy M. Bremnes, E. Wist, S. Kaasa, Barrie R. Cassileth	2003	56
14	The level of physical activity in long-term survivors of testicular cancer European Journal of Cancer ·Lene Thorsen, Wenche Nystad, O. Dahl, O. Klepp, Roy M. Bremnes, E. Wist, S.D. Fosså	2003	54
15	Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway European Journal of Cancer ·Terje Risberg, S. Kaasa, E. Wist, H Melsom	1997	50
16	Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis Acta Oncologica ·Jan Norum, Jan Abel Olsen, E. Wist, Per Eystein Lønning	2006	44
17	Treatment costs in hodgkin's disease: A cost-utility analysis European Journal of Cancer ·Jan Norum, V. Angelsen, E. Wist, Jan Abel Olsen	1996	43
18	Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial European Journal of Cancer ·Ulf Jungnelius, Ulrik Ringborg, S. Aamdal, Jan Mattsson, Ulrika Stierner, Christian Ingvar, P. Malmström, Ronny Andersson, Magnus Karlsson, K. Willman, E. Wist, Göran Bjelkengren, Ronny Westberg	1998	39
19	Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo. PubMed ·Roy M. Bremnes, L Slørdal, E. Wist, Jarle Aarbakke	1989	38
20	Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival Breast Cancer Research and Treatment ·Hanne Frydenberg, Inger Thune, Trygve Lofterød, E. Mortensen, Anne Elise Eggen, Terje Risberg, E. Wist, Vidar G. Flote, A-S Furberg, Tom Wilsgaard, Lars A. Akslen, Anne McTiernan	2016	38

About E. Wist

E. Wist is a scholar working on Oncology, Complementary and alternative medicine, Cancer Research, Reproductive Medicine and Pathology and Forensic Medicine, having authored 55 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (8 papers), Childhood Cancer Survivors' Quality of Life (8 papers), Complementary and Alternative Medicine Studies (7 papers), Testicular diseases and treatments (6 papers), Palliative Care and End-of-Life Issues (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Cancer survivorship and care (4 papers). The work is most often cited by research in Oncology (1.1k citations), Complementary and alternative medicine (336 citations), Cancer Research (292 citations), Pediatrics, Perinatology and Child Health (365 citations) and Reproductive Medicine (154 citations). E. Wist has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include S. Kaasa, Roy M. Bremnes, Terje Risberg, Suzanne Hagen, Tom Wilsgaard, Neil K. Aaronson, Kristin Bjordal, Anne Kvikstad, Jan Norum and Torbjørn Moum. Their work appears in journals such as European Journal of Cancer, British Journal of Cancer, Journal of Clinical Oncology, Acta Oncologica and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact